Literature DB >> 25266023

Superficial and early cancers of the esophagus.

Мikhail Davydov1, Vera V Delektorskaya, Yuri P Kuvshinov, Mikhail Lisovsky, Sergey S Pirogov, Harushi Udagawa, Masaki Ueno, Guiqi Wang.   

Abstract

The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on the evolution of Barrett's dysplasia to early cancer; the early detection of esophageal cancer in China; new technologies of treatment for dysplasia; the prognostic value of molecular markers expression in esophageal squamous cell carcinoma; the follow-up schedule after ablation of high-grade dysplasia; intramucosal cancers; and tubular widespread endoscopic esophageal submucosal dissection with high-dose steroid stricture prevention.
© 2014 New York Academy of Sciences.

Entities:  

Keywords:  Barrett's dysplasia; OESO; esophageal submucosal dissection; intramucosal cancers; molecular markers; steroid stricture prevention

Mesh:

Substances:

Year:  2014        PMID: 25266023     DOI: 10.1111/nyas.12527

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

Review 1.  Comparison of two major staging systems of esophageal cancer-toward more practical common scale for tumor staging.

Authors:  Harushi Udagawa; Masaki Ueno
Journal:  Ann Transl Med       Date:  2018-02

2.  Development and Validation of an Esophageal Squamous Cell Carcinoma Risk Prediction Model for Rural Chinese: Multicenter Cohort Study.

Authors:  Junming Han; Lijie Wang; Huan Zhang; Siqi Ma; Yan Li; Zhongli Wang; Gaopei Zhu; Deli Zhao; Jialin Wang; Fuzhong Xue
Journal:  Front Oncol       Date:  2021-08-30       Impact factor: 6.244

3.  A Novel Deep Learning System for Diagnosing Early Esophageal Squamous Cell Carcinoma: A Multicenter Diagnostic Study.

Authors:  Dehua Tang; Lei Wang; Jingwei Jiang; Yuting Liu; Muhan Ni; Yiwei Fu; Huimin Guo; Zhengwen Wang; Fangmei An; Kaihua Zhang; Yanxing Hu; Qiang Zhan; Guifang Xu; Xiaoping Zou
Journal:  Clin Transl Gastroenterol       Date:  2021-08-04       Impact factor: 4.488

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.